Company / Current Liabilities
DNA X, Inc. Current Liabilities History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$43.7M
FY2024
5-year range
$20.5M / $43.7M
FY2020-FY2024
Trend
+36.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has increased for 3 consecutive years, from $20M in FY2021 to $44M in FY2024.
Based on SEC 10-K filings.
$44M in FY2024 with a 5-year CAGR of +9.6%.
Increased from $32M to $44M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +28.8%
- 5-Year CAGR
- +9.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- DNA X, Inc.'s current liabilities has grown for 3 consecutive years.
- 5-year CAGR of +9.6%, indicating consistent growth.
- In FY2024, current liabilities increased 36.1% year-over-year.
- Lowest current liabilities in the period was in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $43.7M | +36.1% |
| FY2023 | $32.1M | +0.3% |
| FY2022 | $32.1M | +56.6% |
| FY2021 | $20.5M | +0.0% |
| FY2020 | $20.5M | -25.8% |
| FY2019 | $27.6M | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026